Email not displaying properly? View email in your browser
Vertical-Talk Healthcare   Multidrug Resistance
Personalised Cancer Vaccines
Prostate Cancer
  Apr 2023   e-Newsletter Advertise | Editorial Calendar 
kpNext™
Latest e-Book


 Editorial Calendar

Author Guidelines
Articles
  A Structured Review on BCRP-Mediated Multidrug Resistance
Nensi Raytthatha, Research Scholar, Sigma Institute of Pharmacy
Isha Shah, Research Scholar, Sigma Institute of Pharmacy
Breast cancer resistance protein (BCRP)/ATP-binding cassette subfamily G member 2 (ABCG2) is an ATP-binding cassette (ABC) transporter that has been implicated as a molecular cause of multidrug resistance (MDR) in a variety of cancer cells.It got its name from being cloned from a multidrug-resistant breast cancer cell line, where it was discovered to impart resistance to chemotherapeutic drugs including mitoxantrone...
Medical Fair Thailand 2023
MasterControl Korea
News
Boehringer Ingelheim Inaugurates the New...
Lantheus and POINT Biopharma Announce...
Techno Trends
 Moderna and Merck Developed Novel mRNA-4157/V940...
  Janssen Pharmaceutical Discovered First-of-its-Kind ERLEADA®...
  Regenxbio Discovered Novel RGX-202 for the Tretament of Duchenne...
Bora Pharmaceuticals
Press Releases
Medigene presents final Phase I data of TCR-T...
Salix Partners with the Colorectal Cancer...
Projects
 AtomVie Global Radiopharma to Open New Radiotherapeutics Facility...
 Samsung Biologics Invests US $1.46 billion (KRW 1.9 trillion) for the...
 Evonik Constructs New Pharmaceutical Lipids Facility in Indiana, USA
MasterControl
Events
28 - 29 Apr 2023
MEPDPS 2023
03 - 04 May 2023
Clinical Trials Innovation Programme 2023
10 - 11 May 2023
Digi-Tech Pharma & AI
Research Insights
  SARS-CoV-2 Neutralizing Antibodies Longevity, Breadth, and Evasion...
 COVID-19 Infection and Transmission Includes Complex Sequence...
 Clinically Adjudicated Deceased Donor Acute Kidney Injury and Graft...
Whitepapers
  Phase-Appropriate Analytical Method Development
  Subscribe  |  e-book Archives  | Advisory Board  
Follow Us Facebook Facebook Facebook
www.pharmafocusasia.com - Owned by Ochre Media Pvt. Ltd.